Are There Clinically Significant Differences Among the Second Generation ALK Inhibitors? episode artwork

EPISODE · Dec 10, 2015 · 4 MIN

Are There Clinically Significant Differences Among the Second Generation ALK Inhibitors?

from GRACEcast · host cancerGRACE Meetings

Drs. Ben Solomon, Leora Horn, & Jack West evaluate the evidence and consider whether there are clinically significant differences among the second generation ALK inhibitors that would lead to a reason to prefer one over another for a particular patient.

Episode metadata supplied by the publisher feed · Published Dec 10, 2015

Embed this episode

NOW PLAYING

Are There Clinically Significant Differences Among the Second Generation ALK Inhibitors?

0:00 4:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 4 minutes long.

When was this GRACEcast episode published?

This episode was published on December 10, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!